LFG
SLS icon

Larson Financial Group’s SELLAS Life Sciences SLS Stock Holding History

Larson Financial Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Sell
7,010
-3
-0% -$21 ﹤0.01% 1166
2026
Q1 		$29.7K Buy
7,013
+20
+0.3% +$89 ﹤0.01% 1632
2025
Q4 		$26.4K Buy
+6,993
New +$13.6K ﹤0.01% 1560

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Larson Financial Group's SLS Position: Q2 2026 in Review

Larson Financial Group reduced its SELLAS Life Sciences (SLS) stake by 0.04% in Q2 2026, selling an estimated $21 and leaving 7,010 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #1166.

Larson Financial Group first reported a position in SLS in Q4 2025 and has held it in 3 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Larson Financial Group held 7,010 shares of SELLAS Life Sciences worth $103K as of Q2 2026.
  • Larson Financial Group sold 3 SELLAS Life Sciences shares in Q2 2026, an estimated $21.
  • SELLAS Life Sciences made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1166 holding.
  • Larson Financial Group first reported a position in SELLAS Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.